Tillotts Pharma AG acquires Haupt Pharma Wülfing
Pharmaceutical production, solid dosage forms · Gronau, Germanyacquired byTillotts Pharma AG
Tillotts Pharma acquires Haupt Pharma Wülfing GmbH, based in Gronau with around 280 employees. The site produces solid dosage forms and is the central manufacturer of Asacol in the Tillotts portfolio.
- Buyer
- Tillotts Pharma AG
- Target
- Haupt Pharma Wülfing, Gronau
- Type
- Strategic
- Sector
- Healthcare & Medtech
- Country
- Germany
- First reported
- 26/10/2026
- Source
- ots.at
Deal-Radar no. 44-029 · publicly reported, without guarantee · SourcingClub was not involved in this transaction. Report an error · Method
Transactions by Tillotts Pharma AG
So far this is the only transaction by Tillotts Pharma AG published in the Deal-Radar. New deals are added every Monday.
Strategic and succession in Week 44/2026
All deals in October 2026Every Monday, all deals of the previous week, with source.
Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 30 October 2026.